Skip to main content
Program
Login Required
Poster Gallery
Browse by Category
Browse by Poster Number
Browse by Title
Browse by Author
Poster Wall
Sponsors
Exhibits
Exhibit Hall
Exhibitor List
Restricted Access
Delegates
Speakers
Attendees
CE Information/Evaluation
CE Information
Faculty Disclosures
Evaluation/Claim CE
iwCLL Committees & Membership
FAQ
Toggle navigation
Login
Search
Home
Program
Login Required
Poster Gallery
Browse by Category
Browse by Poster Number
Browse by Title
Browse by Author
Poster Wall
Sponsors
Exhibits
Exhibit Hall
Exhibitor List
Restricted Access
Delegates
Speakers
Attendees
CE Information/Evaluation
CE Information
Faculty Disclosures
Evaluation/Claim CE
iwCLL Committees & Membership
FAQ
iwCLL X / Twitter
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Browse by Poster Title
Home
Browse by Poster Title
Browse by Poster Title
5 results found
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
Sort by
#
Sort by
Title
O
1221
Occurrence and Evolution of Autoimmune Cytopenias in Chronic Lymphocytic Leukemia Patients treated with Venetoclax: a study of the French Innovative Leukemia Organization (FILO).
Past, Present, and Future in CLL
Favorite
1152
Optical genome mapping and fluorescence in situ hybridization is the best combination to identify genomic complexity and TP53 deletions in CLL patients
Pathogenesis of CLL
Favorite
3009
Orelabrutinib combined with bendamustine and obinutuzumab as the first-line treatment for chronic lymphocytic leukemia/small lymphocytic leukemia: a phase II multicenter exploratory study
Therapy of CLL
Favorite
1226
Outcomes of Tixagevimab/cilgavimab pre-exposure prophylaxis in Chronic lymphocytic leukemia patients- a single center experience
Clinical Challenges in CLL
Favorite
2018
Over-Time Monitoring of CXCR4dim/CD5bright Proliferative Fraction Anticipates Relapse In Ibrutinib-Treated CLL : a reservoir for BTK mutations?
Clinical Challenges in CLL
Favorite
Back to Top